Harmony Biosciences Holdings (HRMY) Financials

$41.62

$-0.45 (-1.07%)

As on 09-Sep-2026 16:00EDT

Market cap

$2,460 Mln

Revenue (TTM)

$960 Mln

P/E Ratio

13.6

P/B Ratio

2.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	959.90	868.45	714.73	582.02	437.86	305.44
Cost of Revenue	235.91	198.34	156.82	121.24	83.48	55.52
Gross Profit	723.99	670.11	557.92	460.79	354.37	249.92
Operating Expenses	493.34	461.64	367.09	268.76	234.19	162.39
Operating Profit (EBIT)	230.65	208.47	190.83	192.03	120.19	87.53
Other Income	--	--	--	--	0.17	-26.13
Profit before Tax	241.20	215.06	191.80	173.40	104.69	37.43
Provision for Tax	59.93	56.38	46.31	44.54	-76.78	2.83
Profit after Tax (Net Income)	181.27	158.69	145.49	128.85	181.47	34.60
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	181.47	34.60

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	999.24	870.22	659.16	466.99	402.84	186.51
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	139.77	149.28	164.96	180.68	192.15	193.16
Current Liabilities	234.07	252.13	175.08	163.78	78.88	53.78
Total Liabilities	1,607.15	1,271.63	999.20	811.45	673.87	433.44

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	558.75	364.62	419.95	360.38	273.59	149.00
Current Assets	814.33	907.01	579.25	451.07	400.29	284.44
Total Assets	1,607.15	1,271.63	999.20	811.45	673.87	433.44
Total Debt*	153.96	239.58	181.41	193.57	191.65	195.74
Net Current Assets	580.26	654.88	404.17	287.29	321.40	230.66

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	348.20	219.82	219.39	144.47	98.56
Cash Flow from Investing Activities	--	-39.65	-67.48	-46.44	-141.83	-100.30
Cash from Financing Activities	--	-9.05	-11.00	-105.55	6.84	7.42
Net Cash Inflow / Outflow	--	--	--	--	9.48	5.68

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	3.09	2.70	2.50	2.19	2.94	0.57
Cash EPS ($)	--	3.14	2.91	2.60	3.32	0.89
Adjusted Book Value ($)	--	14.83	11.32	7.93	6.54	3.09
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	5.93	3.78	3.73	2.34	1.63
Free Cash Flow per Share ($)	--	5.93	3.76	3.72	2.34	1.63

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	16.27	19.38	20.53	37.16	10.27
ROE (%)	19.39	20.75	25.84	29.63	61.58	24.39
ROA (%)	12.52	13.98	16.07	17.35	32.78	8.04
EBIT Margin (%)	26.15	26.45	29.28	33.87	28.20	20.17
Net Margin (%)	18.88	18.27	20.36	22.14	41.43	12.39
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	24.25	0.22	0.23	0.33	0.43	0.91
EBIT Growth (%)	4.09	9.75	6.16	59.66	100.38	806.35
Net Profit Growth (%)	0.20	9.07	12.91	-28.99	424.52	193.65
EPS Growth (%)	-0.54	0.08	0.14	-0.26	4.13	1.88
Book Value Growth (%)	28.50	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	13.59	13.84	13.77	14.75	18.71	74.34
Price / Book Value	2.50	2.52	3.04	4.07	8.43	13.79
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	7.08	6.51	7.36	7.86	22.22	31.48
Close Price ($)	36.41	37.42	34.41	32.30	55.10	42.64
High Price ($)	40.87	40.93	41.61	55.60	62.09	45.20
Low Price ($)	25.52	25.52	28.14	18.61	31.54	25.09
Market Cap ($ Cr)	2,460.49	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.13	0.28	0.28	0.41	0.48	1.05
Short term debt to equity ratio	0.02	0.10	0.03	0.03	0.00	0.02
Current Ratio	3.48	3.60	3.31	2.75	5.07	5.29
Quick Ratio	3.45	3.58	3.27	2.72	5.02	5.21
Interest Coverage	18.89	15.68	11.96	8.30	6.57	2.55

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	11.56	11.14	11.62	12.74	12.50	11.41
Asset Turnover	0.66	0.76	0.79	0.78	0.79	0.71
Receivable days	--	37.81	40.16	40.44	37.36	34.09
Inventory Days	--	11.56	14.63	14.55	19.10	27.15
Payable days	--	28.95	36.65	32.41	10.47	11.70
Cash Conversion Cycle	--	20.43	18.13	22.58	45.99	49.55

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.